Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Aminobutyric Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for GABA derivative intermediates featuring high purity and mild conditions. Enables cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN108866028B details a mutant amino lyase for producing (R)-3-aminobutyric acid. This biocatalytic route offers superior stereoselectivity and cost efficiency for Dolutegravir intermediates.
Patent CN104370755A reveals efficient synthesis for Dolutegravir intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturers.